VY

Victor Yaw

Investor at Iterative Health

Victor Y. is a seasoned entrepreneur and investor, currently serving as Co-Founder at Codex PBC, where efforts are focused on developing a stablecoin-native blockchain. As a Venture Partner and Head of Europe at Blue Cloud Ventures since July 2020, Victor Y. specializes in providing tailored growth capital to rapidly growing enterprise SaaS and fintech firms, contributing to investments in notable companies such as Trulioo and Go1. In addition, Victor Y. is an investor at Iterative Health, which aims to revolutionize gastrointestinal disease care through artificial intelligence, and has recently served as a Board Observer for LMS365, a learning platform integrated with Microsoft 365. Previous experience includes a role in Corporate & Investment Banking at BNP Paribas CIB. Victor Y. holds a Bachelor of Business Administration in Finance and Art History from Washington University in St. Louis, and completed high school at Choate Rosemary Hall following the International Baccalaureate at Anglo-Chinese School (Independent).

Links


Org chart

No direct reports

Teams

This person is not in any teams


Offices

This person is not in any offices


Iterative Health

1 followers

Iterative Health is pioneering the use of artificial intelligence-based precision medicine in gastroenterology (GI), with the aim of helping to optimize clinical trials investigating treatment of inflammatory bowel disease (IBD). We use advanced machine learning and computer vision to interpret endoscopic images along with other types of data, helping clinicians to better assess patients with potential GI problems. This gives practitioners enhanced capabilities in the detection, annotation, disease scoring and treatment of GI related diseases. Iterative Health is initially applying these advances towards standardizing disease severity characterization for inflammatory bowel disease. Ultimately, the company aims to establish more meaningful endpoints to serve as better predictors of both therapeutic response and disease outcomes. The company is headquartered in Cambridge, Massachusetts.


Employees

51-200

Links